Skip to toolbar
  • Log in
A Dose of Reality
Login
Skip to content
  • Home
  • Site-Wide Activity
  • Blog
  • Forums
  • Groups
  • Members
  • Resources

A Dose of Reality

Disproving hypothesis clears path for research for new treatment …

March 10, 2016 by Jeremy Leave a reply

Researchers reported negative results from the first repeated-dose study of a dopamine-1 receptor (D1R) agonist for treating cognitive and negative symptoms of schizophrenia.Based on earlier preclinical research suggesting …

Visit site: 

Disproving hypothesis clears path for research for new treatment …

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Google+ (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)

Post navigation

← Oxytocin can improve compassion in people with symptoms of PTSD … Killswitch Engage's Jesse Leach on Battling Mental Illness – Loudwire →

Copyright © 2018 A Dose of Reality  ·  Site by Jeremy Lawson

  • Home
  • Register
  • Resources
  • Privacy Policy
  • Terms of Service
  • Contact

@

Not recently active